Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel

Before implementation, collect baseline data and agree metrics to be collected during and after implementation (see measuring success for more details).

Consult all stakeholders to ensure clinical confidence in using faecal calprotectin testing in both primary and secondary care (see project management for more details).

Consider implementing faecal calprotectin testing on a pilot basis in a limited number of practices (see insights from the NHS for more details).

Agree cut‑off values and subsequent local referral pathways to maximise the benefit of the test (see insights from the NHS for more details).

Clearly define the patient selection criteria and how many patients will be expected to benefit from the introduction of the test. This will be key to how cost effective the technology will be and will contribute to NHS organisations' case for change and development of a business case (see insights from the NHS for more details).